A method to increase the number of growth hormone receptors at the surface of cells

This publication has 29 references indexed in Scilit:

• The Ubiquitin-Proteasome Pathway Regulates the Availability of the GH Receptor
  Endocrinology, 2002
• Ubiquitin-mediated degradation of cellular proteins in health and disease
  Hepatology, 2002
• The Proteasome
  American Journal of Clinical Pathology, 2001
• Phorbol Ester- and Growth Factor-Induced Growth Hormone (GH) Receptor Proteolysis and GH-Binding Protein Shedding: Relationship to GH Receptor Down-Regulation
  Endocrinology, 2001
• Tumor Necrosis Factor- Converting Enzyme (TACE) Is a Growth Hormone Binding Protein (GHBP) Sheddase: The Metalloprotease TACE/ADAM-17 Is Critical for (PMA-Induced) GH Receptor Proteolysis and GHBP Generation
  Endocrinology, 2000
• Blockade of Growth Hormone Receptor Shedding by a Metalloprotease Inhibitor
  Endocrinology, 1998
• Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.
  Journal of Clinical Investigation, 1997
• Diverse Cell Surface Protein Ectodomains Are Shed by a System Sensitive to Metalloprotease Inhibitors
  Published by Elsevier ,1996
• Metalloproteinase-mediated release of human Fas ligand.
  The Journal of Experimental Medicine, 1995
• The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins
  Journal of Clinical Endocrinology & Metabolism, 1992